The evolving landscape of tyrosine kinase inhibitors in chronic-phase chronic myeloid leukemia: A 25-year journey

Blood Reviews , Nov 2026

Haddad FG et al. Blood Rev, October 2026 (epub ahead of print)

Link to full abstract